We are live on ! Find out more
SC

Saturna Capital Portfolio holdings

AUM $7.13B
1-Year Est. Return 35.47%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+35.47%
3 Year Est. Return
+92.6%
5 Year Est. Return
+130.56%
10 Year Est. Return
+515.97%
AUM
$7.65B
AUM Growth
+$112M
Cap. Flow
-$72.9M
Cap. Flow %
-0.95%
Top 10 Hldgs %
44.49%
Holding
170
New
4
Increased
63
Reduced
46
Closed
12

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$105M
2
KVUE icon
Kenvue
KVUE
+$6.36M
3
AVGO icon
Broadcom
AVGO
+$2.78M
4
MSFT icon
Microsoft
MSFT
+$1.16M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$671K

Top Sells

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$80.4M
2
LLY icon
Eli Lilly
LLY
+$30.1M
3
CSCO icon
Cisco
CSCO
+$22.7M
4
BMY icon
Bristol-Myers Squibb
BMY
+$12.1M
5
AAPL icon
Apple
AAPL
+$10M

Sector Composition

Rank Sector Weight
1 Technology 46.65%
2 Healthcare 23.02%
3 Industrials 12.1%
4 Consumer Staples 6.52%
5 Consumer Discretionary 6.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.03T
$575M 7.52%
649,411
-33,487
-5% -$30.1M
AAPL icon
2
Apple
AAPL
$4.9T
$497M 6.51%
2,134,890
-44,903
-2% -$10M
MSFT icon
3
Microsoft
MSFT
$3.35T
$478M 6.26%
1,111,853
+2,720
+0.2% +$1.16M
TSM icon
4
TSMC
TSM
$2.09T
$370M 4.84%
2,133,023
+2,617
+0.1% +$446K
ASML icon
5
ASML
ASML
$634B
$266M 3.48%
319,554
+395
+0.1% +$353K
NVDA icon
6
NVIDIA
NVDA
$4.72T
$264M 3.45%
2,174,658
-4,373
-0.2% -$517K
NVO
7
Novo Nordisk
NVO
$228B
$254M 3.32%
2,132,038
-3,967
-0.2% -$529K
AVGO icon
8
Broadcom
AVGO
$1.85T
$254M 3.32%
1,471,015
+17,355
+1% +$2.78M
GOOGL icon
9
Alphabet (Google) Class A
GOOGL
$4.08T
$237M 3.1%
1,430,995
+4,003
+0.3% +$671K
JCI icon
10
Johnson Controls International
JCI
$87.8B
$205M 2.68%
2,641,639
+368
+0% +$25.8K
AMD icon
11
Advanced Micro Devices
AMD
$791B
$199M 2.61%
1,215,870
– –
INTU icon
12
Intuit
INTU
$86.3B
$184M 2.4%
295,503
-2,470
-0.8% -$1.58M
ADBE icon
13
Adobe
ADBE
$98.5B
$176M 2.3%
339,060
-1,605
-0.5% -$880K
NOW icon
14
ServiceNow
NOW
$114B
$169M 2.21%
943,990
+950
+0.1% +$156K
ORCL icon
15
Oracle
ORCL
$367B
$163M 2.13%
957,562
-2,019
-0.2% -$292K
PG icon
16
Procter & Gamble
PG
$335B
$160M 2.09%
921,002
+1,286
+0.1% +$218K
TT icon
17
Trane Technologies
TT
$97.3B
$157M 2.05%
403,869
+560
+0.1% +$194K
TJX icon
18
TJX Companies
TJX
$176B
$145M 1.89%
1,230,875
+234
+0% +$26.8K
KEYS icon
19
Keysight
KEYS
$53.4B
$138M 1.81%
869,865
+278
+0% +$39.6K
A icon
20
Agilent Technologies
A
$39.2B
$134M 1.76%
905,686
-4,780
-0.5% -$654K
ABBV icon
21
AbbVie
ABBV
$455B
$134M 1.75%
676,176
+560,808
+486% +$105M
AZN icon
22
AstraZeneca
AZN
$266B
$130M 1.71%
837,426
+1,321
+0.2% +$213K
AZO icon
23
AutoZone
AZO
$49.1B
$128M 1.67%
40,638
+22
+0.1% +$67.5K
CHD icon
24
Church & Dwight Co
CHD
$23.1B
$125M 1.63%
1,191,893
+26
+0% +$2.67K
LOW icon
25
Lowe's Companies
LOW
$118B
$116M 1.52%
429,635
+269
+0.1% +$65.1K
1
2 3 4 5

Similar funds

FPA
First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return
UB
UMB Bank Kansas City, Missouri $7.16B AUM 20.88% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Saturna Capital's Q3 2024 Portfolio in Review

As of Q3 2024, Saturna Capital held 170 positions worth $7.65B, up 1.5% from $7.53B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Saturna Capital's Q3 2024 filing shows 4 new, 63 increased, 46 reduced and 12 closed positions. Its largest new stake was Argan: 3,894 shares worth $395K. The largest sale was Idexx Laboratories, an estimated $80.4M.

By sector, the portfolio is most concentrated in Technology at 47% of assets, down from 47% a quarter earlier, followed by Healthcare and Industrials.

  • Saturna Capital's largest Q3 2024 buy was Argan: 3,894 shares worth $395K.
  • Saturna Capital added most to AbbVie in Q3 2024, an estimated $105M increase.
  • Saturna Capital's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $30.1M.
  • Saturna Capital fully exited Idexx Laboratories in Q3 2024, selling an estimated $80.4M.
  • Saturna Capital's ten largest holdings make up 44% of its $7.65B portfolio in Q3 2024.
  • Saturna Capital opened 4 new positions and closed 12 in Q3 2024.
  • Saturna Capital's portfolio value rose 1.5% quarter-over-quarter to $7.65B.

Based on Saturna Capital's 13F filing for Q3 2024, filed 5 Nov 2024.